Kutikov points out that not every mass needs to be resected and that patients need to understand the risks associated with each decision they make in the treatment process.
Alexander Kutikov, MD, FACS
Advertisement
Articles by Alexander Kutikov, MD, FACS
Alexander Kutikov, MD, FACS, attending surgeon, Urologic Oncology, associate professor, Urologic Oncology, Fox Chase Cancer Center, discusses neoadjuvant chemotherapy for the treatment of patients with bladder cancer.
Advertisement
Latest Updated Articles
Neoadjuvant Chemotherapy for the Treatment of Patients With Bladder CancerPublished: July 27th 2015 | Updated:
Dr. Alexander Kutikov on Options Afforded to Kidney Cancer PatientsPublished: January 15th 2016 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
4
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
5
